To explore the clinical efficacy of Traditional Chinese Medicine bath in the treatment of psoriasis vulgaris with blood-heat syndrome and its effect on related cytokines based on different temperature and different concentratio
- Conditions
- psoriasis
- Registration Number
- ITMCTR1900025342
- Lead Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Hospitalized patient;
(2) Cases corresponding to diagnosis standards of western medicine and diagnosed as psoriasis vulgaris;
(3) Cases corresponding to diagnosis standards psoriasis vulgaris with blood-heat syndrome of TCM ;
(4) Cases with psoriasis vulgaris corresponding to the progressive stage of psoriasis vulgaris;
(5) Between the ages of 18 and 65 years old,and the gender and course of disease are unlimited;
(6) Cases agree to Sign informed consent form, voluntarily accept and cooperate with treatment, examination and observation.
(1) Women who are pregnant, lactating or ready for pregnancy;
(2) Cases who are allergic to the drug, or allergic to drug ingredients;
(3) Psoriatic arthritis, pustular psoriasis and erythrodermic psoriasis;
(4) Steroid drugs have been taken in recent 2 weeks, and / or steroids have been used intravenously within 1 week.
(5) Complicated with serious original diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system diseases;
(6) Cases with active pulmonary tuberculosisacute and chronic hepatitis and other infectious diseases;
(7) Cases who could not restrain themselves, such as psychosisepilepsy, etc.
(8) External injury or infection on the body surface;
(9) Female patients with menstruation during hospitalization.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PASI;
- Secondary Outcome Measures
Name Time Method confocal laser scanning microscope;IL-23;TNF-a;VEGF;IL-17;Pruritus score;DLQI;evaluation of curative effect;